RayClinic AB announced on the 27th of February 2009 that the company has decided to apply for a financial reconstruction. With reference to what is stated above, the NASDAQ OMX Stockholm AB has decided that the ser. B shares in RayClinic AB (ISIN code SE0001457797 and order book ID 38098) will be placed on the observation segment until further notice. The shares will be transferred with effect from Tuesday, March 3rd, 2009.
Attachments
